HighPoint Advisor Group LLC Increases Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

HighPoint Advisor Group LLC grew its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,897 shares of the biotechnology company’s stock after purchasing an additional 38 shares during the period. HighPoint Advisor Group LLC’s holdings in Axon Enterprise were worth $2,316,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in AXON. New Wave Wealth Advisors LLC purchased a new stake in Axon Enterprise during the fourth quarter worth $40,000. Y.D. More Investments Ltd purchased a new position in Axon Enterprise in the fourth quarter valued at $45,000. Prestige Wealth Management Group LLC raised its position in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares during the period. Stonebridge Financial Group LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter worth about $53,000. Finally, GPS Wealth Strategies Group LLC grew its position in shares of Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after acquiring an additional 40 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Down 1.7 %

Shares of Axon Enterprise stock opened at $525.95 on Tuesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock’s 50 day simple moving average is $588.26 and its 200-day simple moving average is $551.61. The stock has a market cap of $40.30 billion, a P/E ratio of 135.90, a P/E/G ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Barclays reissued a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Finally, TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $604.67.

Insider Buying and Selling

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.